News and Events
Stay up to date with news and events
Pridopidine Hits a Roadblock: EMA Says No to Approval for Huntington’s Disease Treatment
We learned on July 25, 2025 that Prilenia’s application to the European Medicines Agency’s (EMA) for pridopidine was not accepted for marketing authorization. While this…
When the Brain’s Orchestra Falls Out of Tune: A New Map of Huntington’s Disease Progression
An international collaboration between world leaders in Huntington’s disease (HD) that spans both academia and pharmaceutical companies is giving us new insight into how HD…
Stopping the Genetic Snowball: How a simple genetic interruption slows Huntington’s disease
While the genetic change that causes Huntington’s disease (HD) leads to several problems for cells, researchers believe they could stem from one core issue: the…
Cracking the Case: How a Smartphone “Detective” is Helping Track Huntington’s Disease Progression
team of researchers from Roche and University College London (UCL) have developed a new clinical measure called the Huntington’s Disease Digital Motor Score (HDDMS). This…
Unsung Heroes: Could Glial Cells Treat Huntington’s Disease?
New research is challenging how we think about treating brain diseases, like Huntington’s disease (HD). A study from the lab of Dr. Steven Goldman shows…